1-(2,6-Dichlorobenzyl)-1H-indole-3-carbaldehyde

Catalog No. :
ACZGFS813
CAS No. :
93548-80-2
Molecular Formula :
C16H11Cl2NO
Molecular Weight :
304.18

IUPAC Name:1-(2,6-dichlorobenzyl)-1H-indole-3-carbaldehyde

1-(2,6-Dichlorobenzyl)-1H-indole-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$176.00Login to see priceInquiryInquiry
1g95%$409.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2,6-Dichlorobenzyl)-1H-indole-3-carbaldehyde
IUPAC Name1-(2,6-dichlorobenzyl)-1H-indole-3-carbaldehyde
MDL No.MFCD02221304
Molecular FormulaC16H11Cl2NO
Molecular Weight304.18
SMILESO=CC1=CN(CC2=C(Cl)C=CC=C2Cl)C3=C1C=CC=C3
InChI KeyKOLMFQSIWCNEIG-UHFFFAOYSA-N
SynonymART-CHEM-BB B014319;AKOS B014319;1-(2,6-DICHLOROBENZYL)-1H-INDOLE-3-CARBALDEHYDE;1-(2,6-dichlorobenzyl)indole-3-carbaldehyde;1-[(2,6-dichlorophenyl)methyl]-3-indolecarboxaldehyde;1-[(2,6-dichlorophenyl)methyl]indole-3-carbaldehyde;AN-648/13413005;BIM-0012959.P001
CAS No.93548-80-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZGFS813 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOHWJ835 route compound structure diagram
    ACOHWJ835487-89-8 In Stock
  4. Then
  5. ACZGFS813 route product structure diagram
    ACZGFS81393548-80-2
Inquiry

2. ACZGFS813 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZGFS813 route product structure diagram
    ACZGFS81393548-80-2
Inquiry

Comments (0)